Shu Fang, Lv Shun, Qin Yan, Ma Xinlu, Wang Xin, Peng Xiaozhong, Luo Ying, Xu Bing-E, Sun Xiaoqing, Wu Jun
Shanghai Genomics Inc., Chinese National Human Genome Center, Shanghai, Zhangjiang Hi-Tech Park, Shanghai 201203, China.
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9248-53. doi: 10.1073/pnas.0703327104. Epub 2007 May 21.
Cyclin-dependent kinases (CDKs) are crucial regulators of the eukaryotic cell cycle whose activities are controlled by associated cyclins. PFTK1 shares limited homology to CDKs, but its ability to associate with any cyclins and its biological functions remain largely unknown. Here, we report the functional characterization of human PFTK1 as a CDK. PFTK1 specifically interacted with cyclin D3 (CCND3) and formed a ternary complex with the cell cycle inhibitor p21(Cip1) in mammalian cells. We demonstrated that the kinase activity of PFTK1 depended on CCND3 and was negatively regulated by p21(Cip1). Moreover, we identified the tumor suppressor Rb as a potential downstream substrate for the PFTK1/CCND3 complex. Importantly, knocking down PFTK1 expression by using siRNA caused cell cycle arrest at G(1), whereas ectopic expression of PFTK1 promoted cell proliferation. Taken together, our data strongly suggest that PFTK1 acts as a CDK that regulates cell cycle progression and cell proliferation.
细胞周期蛋白依赖性激酶(CDK)是真核细胞周期的关键调节因子,其活性受相关细胞周期蛋白的控制。PFTK1与CDK具有有限的同源性,但其与任何细胞周期蛋白结合的能力及其生物学功能在很大程度上仍不清楚。在这里,我们报告了人类PFTK1作为一种CDK的功能特性。PFTK1在哺乳动物细胞中与细胞周期蛋白D3(CCND3)特异性相互作用,并与细胞周期抑制剂p21(Cip1)形成三元复合物。我们证明PFTK1的激酶活性依赖于CCND3,并受到p21(Cip1)的负调控。此外,我们确定肿瘤抑制因子Rb是PFTK1/CCND3复合物的潜在下游底物。重要的是,使用小干扰RNA敲低PFTK1的表达会导致细胞周期在G1期停滞,而PFTK1的异位表达则促进细胞增殖。综上所述,我们的数据强烈表明PFTK1作为一种CDK,调节细胞周期进程和细胞增殖。